Schedule of cash and cash equivalents |
| |
2022 | | |
2021 | |
| |
A$ | | |
A$ | |
Cash at bank1 | |
| 6,011,368 | | |
| 2,172,499 | |
| |
2022 | | |
2021 | |
| |
A$ | | |
A$ | |
Cash and cash equivalents | |
| 6,011,368 | | |
| 2,172,499 | |
|
Schedule of reconciliation of loss after tax to net cash outflow from operating activities |
| |
Restated
2022 | | |
2021 | |
| |
A$ | | |
A$ | |
Loss from ordinary activities after income tax | |
| (20,076,843 | ) | |
| (14,060,992 | ) |
Adjustments for non-cash items: | |
| | | |
| | |
Depreciation and amortisation | |
| 363,695 | | |
| 349,387 | |
Impairment expense | |
| 4,175,993 | | |
| 2,812,687 | |
Share-based payments expense | |
| 7,452,583 | | |
| 7,295,966 | |
Finance costs | |
| - | | |
| 250,668 | |
Fair value loss on convertible notes | |
| 781,492 | | |
| - | |
Unrealised foreign currency losses | |
| 142,836 | | |
| (233,179 | ) |
Accrued interest | |
| (155,157 | ) | |
| (34,881 | ) |
| |
| | | |
| | |
Movement in assets and liabilities: | |
| | | |
| | |
Decrease/(increase) in prepaid expenses | |
| 9,542 | | |
| (610,787 | ) |
Decrease in inventories | |
| - | | |
| 4,734 | |
Decrease/(increase) in trade and other receivables | |
| 192,124 | | |
| 50,822 | |
(Increase) in investments | |
| (2,565,082 | ) | |
| - | |
(Decrease)/increase in employee liabilities/provisions | |
| 7,106 | | |
| 126,528 | |
(Decrease)/increase in deferred income | |
| (132,800 | ) | |
| 132,800 | |
(Decrease)/increase in trade and other payables | |
| (54,288 | ) | |
| (185,839 | ) |
Net cash flow used in operating activities | |
| (9,858,799 | ) | |
| (4,102,086 | ) |
|